|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,206.00 KRW | +4.33% |
|
+3.97% | -26.91% |
| 05-20 | Aprogen Medicines Inc. announced that it expects to receive KRW 10 billion in funding from N2Tech Co.,Ltd | CI |
| 25-07-24 | N2Tech Co.,Ltd announced that it has received KRW 10 billion in funding | CI |
Company Valuation: N2Tech Co.,Ltd
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 180,730 | 119,150 | 65,840 | 64,320 | 45,055 | 56,939 |
| Change | - | -34.07% | -44.74% | -2.31% | -29.95% | 26.37% |
| Enterprise Value (EV) 1 | 201,908 | 108,612 | 41,255 | 37,209 | 14,345 | 49,077 |
| Change | - | -46.21% | -62.02% | -9.81% | -61.45% | 242.11% |
| P/E | -6.15x | -2.72x | -49.1x | 5.94x | -1.76x | 2.5x |
| PBR | 3.98x | 1.98x | 0.75x | 0.58x | 0.52x | 0.45x |
| PEG | - | 0.2x | 0.5x | -0x | 0x | -0x |
| Capitalization / Revenue | 3.14x | 2.67x | 1.54x | 1.87x | 3.31x | 1.98x |
| EV / Revenue | 3.51x | 2.43x | 0.96x | 1.08x | 1.05x | 1.71x |
| EV / EBITDA | 47.3x | -35.1x | -16.3x | -35.4x | -4.82x | 4.97x |
| EV / EBIT | 121x | -14.8x | -10.7x | -19.4x | -4.07x | 5.2x |
| EV / FCF | -731x | -5.8x | 18.8x | -20.5x | 5.99x | -1.59x |
| FCF Yield | -0.14% | -17.3% | 5.32% | -4.88% | 16.7% | -63.1% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -3,685 | -3,058 | -73.16 | 522.9 | -1,235 | 660 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 57,475 | 44,629 | 42,811 | 34,306 | 13,614 | 28,764 |
| EBITDA 1 | 4,267 | -3,098 | -2,531 | -1,051 | -2,975 | 9,874 |
| EBIT 1 | 1,670 | -7,331 | -3,868 | -1,919 | -3,522 | 9,439 |
| Net income 1 | -19,532 | -33,370 | 1,533 | 10,738 | -25,570 | 18,963 |
| Net Debt 1 | 21,177 | -10,538 | -24,585 | -27,112 | -30,710 | -7,861 |
| Reference price 2 | 22,650.00 | 8,325.00 | 3,595.00 | 3,105.00 | 2,175.00 | 1,650.00 |
| Nbr of stocks (in thousands) | 7,979 | 14,312 | 18,314 | 20,715 | 20,715 | 34,508 |
| Announcement Date | 9/28/20 | 9/17/21 | 3/1/23 | 3/21/24 | 3/21/25 | 3/19/26 |
1KRW in Million2KRW
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 27.94M | |
| 43.43x | 14.08x | 34.24x | 0.59% | 682B | |
| 59.77x | 18.03x | 48.24x | 0.31% | 419B | |
| 46.56x | 10.26x | 32.16x | 1.07% | 208B | |
| 39.95x | 4.11x | 18.69x | 1.3% | 93.08B | |
| 58.89x | 18.98x | 39.4x | 0.65% | 27.47B | |
| 53.71x | 6.99x | 24.72x | 0.29% | 21.15B | |
| 30.55x | 4.63x | 19.55x | 0.99% | 22.08B | |
| 32.35x | 2.37x | 12.91x | 0.5% | 16.77B | |
| 58.67x | 10.7x | 34.04x | - | 15.16B | |
| Average | 47.10x | 10.01x | 29.33x | 0.71% | 150.54B | |
| Weighted average by Cap. | 48.47x | 13.72x | 36.40x | 0.62% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- A227950 Stock
- Valuation N2Tech Co.,Ltd
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
